🇺🇸 FDA
Patent

US 6010905

Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells

expired A61KA61K2239/31A61K2239/58

Quick answer

US patent 6010905 (Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2239/31, A61K2239/58, A61K38/00, A61K40/19